X4 Pharmaceuticals, Inc
XFOR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501697
In the last 90 days, X4 Pharmaceuticals, Inc insiders filed 0 open-market purchases and 2 sales; 89 institutions reported holding it in 13F filings for Q2 2026, worth $463.0M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding X4 Pharmaceuticals, Inc changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 52 | 2 | 52 | +2 |
| Shares | 16.2M | 337.7K | 17.6M | +1.70M (+10.7%) |
| Value | $85.7M | $1.79M | $40.2M | −$43.7M (−52.1%) |
2 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (13)
Institutions that held X4 Pharmaceuticals, Inc at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Point72 Asset Management, L.P. | 1,633,204 | $3.74M | 0.02% |
| Tri Locum Partners LP | 1,578,947 | $3.62M | 1.45% |
| Kennedy Capital Management, Inc. | 131,501 | $301.0K | 0.01% |
| Acadian Asset Management LLC | 57,270 | $130.0K | 0.00% |
| XTX Topco Ltd | 19,938 | $46.0K | 0.03% |
| Connor, Clark & Lunn Investment Management Ltd. | 12,786 | $29.0K | 0.00% |
| Engineers Gate Manager LP | 11,874 | $27.0K | 0.00% |
| Moody Lynn & Lieberson, LLC | 10,000 | $23.0K | 0.00% |
| Mayflower Financial Advisors, LLC | 10,000 | $23.0K | 0.00% |
| High Net Worth Advisory Group LLC | 1,100 | $3.00K | 0.00% |
| UBS Group AG | 668 | $2.00K | 0.00% |
| Rockefeller Capital Management L.P. | 1,000 | $2.00K | 0.00% |
| JPMorgan Chase & Co | 203 | $0 | 0.00% |
Sold out (11)
Institutions that held X4 Pharmaceuticals, Inc at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Altium Capital Management LP | 804,598 | $4.26M |
| Monashee Investment Management LLC | 561,421 | $2.97M |
| Driehaus Capital Management LLC | 505,752 | $2.67M |
| Ergoteles LLC | 68,938 | $365.0K |
| Hudson Bay Capital Management LP | 45,893 | $243.0K |
| HRT Financial LP | 34,719 | $183.0K |
| Minot Wealth Management LLC | 17,000 | $90.0K |
| Trexquant Investment LP | 16,625 | $88.0K |
| Tower Research Capital LLC (TRC) | 1,250 | $7.00K |
| IFP Advisors, Inc | 1,000 | $5.00K |
| Harbour Investments, Inc. | 10 | $0 |
Not filed for Q4 2021 yet (2)
Institutions that held X4 Pharmaceuticals, Inc at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 311,492 | $1.65M |
| Marshall Wace North America L.P. | 26,252 | $139.0K |